e-CTA
BrainomixProduct specifications |
Information source:
Vendor
Last updated: Dec. 29, 2022 |
General | |
---|---|
Product name | e-CTA |
Company | Brainomix |
Subspeciality | Neuro |
Modality | CT |
Disease targeted | Stroke |
Key-features | Collateral assessment, occlusion detection, report generation |
Suggested use | |
Data characteristics | |
Population | all CTA scans with suspicion of stroke |
Input | CT Angiography |
Input format | DICOM |
Output | annotations, collateral score |
Output format | |
Technology | |
Integration | Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 05-2018 |
Distribution channels | Blackford |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | |
Based on | |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance |
|
Other relevant papers |